RELMADA THERAPEUTICS, INC. Fair Value Adjustment of Warrants
RELMADA THERAPEUTICS, INC. (RLMD) reported Fair Value Adjustment of Warrants of $1.93 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-05-12
- RELMADA THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2021-03-31 was $1.93M.
- RELMADA THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2015-03-31 was $0.00.
- RELMADA THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2014-12-31 was $10.41M.
- RELMADA THERAPEUTICS, INC. fair value adjustment of warrants for the quarter ending 2014-09-30 was $4.88M.
- RELMADA THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2018 was $3.31M.
- RELMADA THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2013 was $41.68K, a 218.44% increase from fiscal 2012.
- RELMADA THERAPEUTICS, INC. fair value adjustment of warrants for fiscal 2012 was $13.09K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month | Fair Value Adjustment of Warrants 115 month | Fair Value Adjustment of Warrants 118 month |
|---|---|---|---|---|---|---|
| 2021-03-31 | $1.93M 10-Q · filed 2021-05-12 | |||||
| 2018-06-30 | $3.31M 10-KT · filed 2020-03-26 | |||||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $10.41M derived: sum of 2 quarters · filed 2015-05-15 | $15.30M 10-Q · filed 2015-05-15 | |||
| 2014-12-31 | $10.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-13 | $15.30M 10-Q · filed 2015-02-13 | ||||
| 2014-09-30 | $4.88M 10-Q · filed 2015-11-06 | |||||
| 2014-03-31 | $54.77K 8-K · filed 2014-05-27 | |||||
| 2013-12-31 | $41.68K 10-K · filed 2015-09-11 | $54.77K 8-K · filed 2014-05-27 | ||||
| 2012-12-31 | $13.09K 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |